ZA955741B - A novel drug delivery system - Google Patents
A novel drug delivery systemInfo
- Publication number
- ZA955741B ZA955741B ZA955741A ZA955741A ZA955741B ZA 955741 B ZA955741 B ZA 955741B ZA 955741 A ZA955741 A ZA 955741A ZA 955741 A ZA955741 A ZA 955741A ZA 955741 B ZA955741 B ZA 955741B
- Authority
- ZA
- South Africa
- Prior art keywords
- pct
- delivery system
- drug delivery
- date jan
- sec
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9413951A GB2290965A (en) | 1994-07-11 | 1994-07-11 | Multiple layer capsules for drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA955741B true ZA955741B (en) | 1997-01-07 |
Family
ID=10758141
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA955741A ZA955741B (en) | 1994-07-11 | 1995-07-11 | A novel drug delivery system |
Country Status (12)
Country | Link |
---|---|
US (1) | US5814338A (xx) |
EP (1) | EP0769938B1 (xx) |
JP (1) | JPH10502376A (xx) |
KR (1) | KR100381208B1 (xx) |
AT (1) | ATE172638T1 (xx) |
AU (1) | AU707076B2 (xx) |
CA (1) | CA2194890A1 (xx) |
DE (2) | DE769938T1 (xx) |
ES (1) | ES2104522T3 (xx) |
GB (1) | GB2290965A (xx) |
WO (1) | WO1996001612A1 (xx) |
ZA (1) | ZA955741B (xx) |
Families Citing this family (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9426079D0 (en) * | 1994-12-23 | 1995-02-22 | Orion Yhtymae Oy | A gelatine capsule |
US5708017A (en) * | 1995-04-04 | 1998-01-13 | Merck & Co., Inc. | Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors |
WO1996040083A2 (en) * | 1995-06-07 | 1996-12-19 | R.P. Scherer Corporation | Methods and compositions for preparing soft gelatin capsules having shells resistant to permeation by fill materials |
US6699885B2 (en) | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US6645988B2 (en) * | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US8563522B2 (en) | 1997-07-08 | 2013-10-22 | The Iams Company | Method of maintaining and/or attenuating a decline in quality of life |
IT1293835B1 (it) * | 1997-08-08 | 1999-03-10 | Foscama Biomed Chim Farma | Composizioni farmaceutiche orali in forma solida a cessione modulata contenenti nicorandil e procedimento per la loro preparazione |
US6531150B1 (en) * | 1997-10-30 | 2003-03-11 | Morishita Jintan Co., Ltd. | Encapsulated unsaturated fatty acid substance and method for producing the same |
NL1009107C2 (nl) * | 1997-11-12 | 1999-06-15 | Banner Pharmacaps Inc | Gelatine-uitspreidende doos met meervoudige, aanpasbare poortklep en meerlagig zacht gel. |
US6096340A (en) * | 1997-11-14 | 2000-08-01 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6174548B1 (en) | 1998-08-28 | 2001-01-16 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
JP4546643B2 (ja) * | 1997-12-08 | 2010-09-15 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 酸不安定な活性化合物を含有する新規の坐剤形 |
DE19801811B4 (de) * | 1998-01-19 | 2004-12-23 | Stada Arzneimittel Ag | Pharmazeutische Zubereitung zur oralen Verabreichung |
DE19814257A1 (de) * | 1998-03-31 | 1999-10-07 | Asta Medica Ag | Brauseformulierungen |
US6733778B1 (en) | 1999-08-27 | 2004-05-11 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
EP1161241B1 (de) * | 1999-03-12 | 2005-12-07 | Aesica Pharmaceuticals Ltd. | Stabile pharmazeutische anwendungsform für paroxetin-anhydrat |
FR2793688B1 (fr) | 1999-05-21 | 2003-06-13 | Ethypharm Lab Prod Ethiques | Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques |
US6423746B1 (en) * | 1999-07-03 | 2002-07-23 | The William M. Yarbrough Foundation | Urushiol induced contact dermatitis and method of use |
DE69907479T2 (de) * | 1999-12-16 | 2004-04-08 | Laboratorio Medinfar-Produtos Farmacéuticos, S. A. | Piroxicam enthaltende gastrointestinale Zubereitung aus merheren Einheiten bestehend |
US7732404B2 (en) | 1999-12-30 | 2010-06-08 | Dexcel Ltd | Pro-nanodispersion for the delivery of cyclosporin |
GB2398499B (en) * | 2000-02-16 | 2004-11-24 | Bioprogress Technology Ltd | Two layer capsules |
US6365181B1 (en) | 2000-04-20 | 2002-04-02 | Gattefosse Corporation | Thixatropic gelatin carrier composition |
US6306435B1 (en) | 2000-06-26 | 2001-10-23 | Yung Shin Pharmaceutical Industrial Co. Ltd. | Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same |
ITMI20011401A1 (it) * | 2001-07-02 | 2003-01-02 | Altergon Sa | Formulazioni farmaceutiche per ormoni tiroidei |
AR034813A1 (es) * | 2001-07-20 | 2004-03-17 | Novartis Ag | Composiciones farmaceuticas y uso de las mismas |
MXPA04007169A (es) * | 2002-01-25 | 2004-10-29 | Santarus Inc | Suministro transmucosal de inhibidores de bomba de protones. |
GB0203296D0 (en) | 2002-02-12 | 2002-03-27 | Glaxo Group Ltd | Novel composition |
US8637512B2 (en) | 2002-07-29 | 2014-01-28 | Glaxo Group Limited | Formulations and method of treatment |
US8168170B2 (en) | 2002-10-03 | 2012-05-01 | The Procter And Gamble Company | Compositions having an inner core and at least three surrounding layers |
MY148805A (en) * | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
TWI319713B (en) * | 2002-10-25 | 2010-01-21 | Sustained-release tramadol formulations with 24-hour efficacy | |
US8487002B2 (en) * | 2002-10-25 | 2013-07-16 | Paladin Labs Inc. | Controlled-release compositions |
CA2517005A1 (en) * | 2003-02-20 | 2004-09-02 | Santarus, Inc. | A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US7247010B2 (en) * | 2003-10-01 | 2007-07-24 | Technophar Equipment & Service Limited | Servo control for capsule making machine |
US20060172006A1 (en) * | 2003-10-10 | 2006-08-03 | Vincent Lenaerts | Sustained-release tramadol formulations with 24-hour clinical efficacy |
US20050118124A1 (en) * | 2003-12-01 | 2005-06-02 | Reinhart Gale M. | Compositions for treating keratinous surfaces |
US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
US7785635B1 (en) | 2003-12-19 | 2010-08-31 | The Procter & Gamble Company | Methods of use of probiotic lactobacilli for companion animals |
US20050152884A1 (en) | 2003-12-19 | 2005-07-14 | The Procter & Gamble Company | Canine probiotic Bifidobacteria globosum |
US8894991B2 (en) | 2003-12-19 | 2014-11-25 | The Iams Company | Canine probiotic Lactobacilli |
US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8815916B2 (en) | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8141226B2 (en) * | 2004-11-02 | 2012-03-27 | Machine Solutions, Inc. | Method of sheathing a stent |
CA2607949C (en) | 2005-05-31 | 2012-09-25 | Thomas William-Maxwell Boileau | Feline probiotic bifidobacteria |
AR052472A1 (es) | 2005-05-31 | 2007-03-21 | Iams Company | Lactobacilos probioticos para felinos |
JP5269595B2 (ja) | 2005-09-09 | 2013-08-21 | アンジェリーニ ラボファーム リミテッド ライアビリティ カンパニー | 1日1回投与用トラゾドン組成物 |
US8298602B2 (en) * | 2005-10-11 | 2012-10-30 | Purecircle Sdn Bhd | Process for manufacturing a sweetener and use thereof |
US20070203040A1 (en) * | 2006-02-24 | 2007-08-30 | Harry Reicherz | Bar soap |
AU2007266574A1 (en) * | 2006-06-01 | 2007-12-06 | Dexcel Pharma Technologies Ltd. | Multiple unit pharmaceutical formulation |
JP5233108B2 (ja) * | 2006-10-24 | 2013-07-10 | ゼリア新薬工業株式会社 | ニザチジン含有医薬組成物 |
AU2008211600B8 (en) | 2007-02-01 | 2014-02-13 | Mars, Incorporated | Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts |
CA2623684A1 (en) * | 2007-03-06 | 2008-09-06 | X.O. Industries Inc. | Spreader box apparatus and method of forming bi-laminar paintball shell material and paintballs for use with paintball gun |
WO2008112227A1 (en) * | 2007-03-12 | 2008-09-18 | Reliant Pharmaceuticals, Inc. | Treatment with nicorandil and omega-3 fatty acids, and a combination product thereof |
US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
FR2936952A1 (fr) * | 2008-10-09 | 2010-04-16 | Monique Bellec | Administration par voie orale de medicaments et complements nutritionnels |
US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
JP5827625B2 (ja) * | 2009-10-29 | 2015-12-02 | アカスティ ファーマ インコーポレイテッド | 濃縮治療用リン脂質組成物 |
ES2364011B1 (es) | 2009-11-20 | 2013-01-24 | Gp Pharm, S.A. | Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares. |
ES2363964B1 (es) | 2009-11-20 | 2012-08-22 | Gp Pharm, S.A. | Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados. |
EP3288556A4 (en) | 2015-04-29 | 2018-09-19 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
MX2019001399A (es) | 2016-08-05 | 2019-09-26 | Taurus Dev Company Llc | Formulacion de calcitonina estable a temperatura ambiente para la via oral. |
US11298336B2 (en) | 2019-05-30 | 2022-04-12 | Soluble Technologies, Inc. | Water soluble formulation |
US11786475B2 (en) | 2020-07-22 | 2023-10-17 | Soluble Technologies Inc. | Film-based dosage form |
AU2023209088A1 (en) * | 2022-01-24 | 2024-08-08 | Ofd Biopharma, Llc | Methods, systems, and materials for making unit dosage forms |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH476499A (de) * | 1964-12-31 | 1969-08-15 | Ciba Geigy | Mischung zum Überziehen von Rektal-Kapseln |
YU36434B (en) * | 1969-05-14 | 1984-02-29 | Sanol Arznei Schwarz Gmbh | Process for obtaining gelation capsules filled with the active substance resistant to gastric juice and dissolvable in the small intestine |
DE2340060A1 (de) * | 1973-08-08 | 1975-02-20 | Scherer Gmbh R P | Magensaftresistente gelatinekapseln und verfahren zu deren herstellung |
DE3437599C2 (de) * | 1984-10-13 | 1987-04-16 | Dolorgiet GmbH & Co KG, 5205 St Augustin | Ibuprofen enthaltende Weichgelatinekapseln |
US4816259A (en) * | 1987-02-12 | 1989-03-28 | Chase Chemical Company, L.P. | Process for coating gelatin capsules |
JPH01232963A (ja) * | 1988-03-14 | 1989-09-18 | Arimento Kogyo Kk | 重層軟カプセルの製造方法 |
DE3818022C2 (de) * | 1988-05-24 | 1994-04-28 | Guenter Stephan | Weichgelatinekapsel |
DE3927113C2 (de) * | 1989-08-17 | 1993-11-25 | Dolorgiet Gmbh & Co Kg | Mittel zur Behandlung von schweren Schmerzzuständen und Verfahren zu ihrer Herstellung |
US5232704A (en) * | 1990-12-19 | 1993-08-03 | G. D. Searle & Co. | Sustained release, bilayer buoyant dosage form |
-
1994
- 1994-07-11 GB GB9413951A patent/GB2290965A/en not_active Withdrawn
-
1995
- 1995-06-24 DE DE0769938T patent/DE769938T1/de active Pending
- 1995-06-24 KR KR1019970700142A patent/KR100381208B1/ko not_active IP Right Cessation
- 1995-06-24 JP JP8504081A patent/JPH10502376A/ja active Pending
- 1995-06-24 EP EP95924940A patent/EP0769938B1/en not_active Expired - Lifetime
- 1995-06-24 US US08/765,952 patent/US5814338A/en not_active Expired - Fee Related
- 1995-06-24 AT AT95924940T patent/ATE172638T1/de not_active IP Right Cessation
- 1995-06-24 WO PCT/EP1995/002488 patent/WO1996001612A1/en active IP Right Grant
- 1995-06-24 CA CA002194890A patent/CA2194890A1/en not_active Abandoned
- 1995-06-24 DE DE69505671T patent/DE69505671T2/de not_active Expired - Fee Related
- 1995-06-24 ES ES95924940T patent/ES2104522T3/es not_active Expired - Lifetime
- 1995-06-24 AU AU29252/95A patent/AU707076B2/en not_active Ceased
- 1995-07-11 ZA ZA955741A patent/ZA955741B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ATE172638T1 (de) | 1998-11-15 |
EP0769938B1 (en) | 1998-10-28 |
DE69505671D1 (de) | 1998-12-03 |
ES2104522T1 (es) | 1997-10-16 |
US5814338A (en) | 1998-09-29 |
DE769938T1 (de) | 1997-09-11 |
EP0769938A1 (en) | 1997-05-02 |
KR970704427A (ko) | 1997-09-06 |
JPH10502376A (ja) | 1998-03-03 |
WO1996001612A1 (en) | 1996-01-25 |
GB9413951D0 (en) | 1994-08-31 |
AU707076B2 (en) | 1999-07-01 |
ES2104522T3 (es) | 1999-03-16 |
AU2925295A (en) | 1996-02-09 |
DE69505671T2 (de) | 1999-06-10 |
GB2290965A (en) | 1996-01-17 |
KR100381208B1 (ko) | 2003-07-18 |
CA2194890A1 (en) | 1996-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9413951D0 (en) | A novel drug delivery system | |
PT1117386E (pt) | Administracao enterica e colonica utilizando capsulas de hpmc | |
CA2182508A1 (en) | Abuse resistant tablets | |
GB2340040B (en) | Microparticles useful as ultrasonic contrast agents and for delivery of drugs into the bloodstream | |
MY112915A (en) | Multiple unit tableted dosage form 1 | |
HUP9800863A3 (en) | Drug delivery system for two or more active substances | |
HU76547A2 (en) | Process for producing pharmaceutical compositions containing agent in polymer-matrix and in solid solution form and these medicaments | |
GR3033301T3 (en) | Medicament form for the delivery of active substances to wounds | |
DE69519685D1 (de) | Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe | |
ID23504A (id) | Komposi-komposi farmasi yang mengandung vitamin d dan kalsium, pembuatan dan penggunaan terapinya | |
ZA200001852B (en) | Sustained release information. | |
AR011437A1 (es) | Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento. | |
MX9805939A (es) | Formas solidas de administracion, de liberacion instantanea y procesos para su produccion. | |
CA2273272A1 (en) | Immediate release drug delivery forms | |
AU668767B2 (en) | Oral medicament form | |
SE9503620D0 (sv) | Användning av proteinet S-100b i läkemedel samt läkemedel innehållande proteinet S-100b | |
FR2679777B1 (fr) | Microcapsules contenant des substances amphiphiles et hydrosolubles, leur procede de preparation ainsi que leurs applications en chirurgie et en medecine. | |
TR199901237T2 (xx) | Bir tienilsiklohegzilamin t�revinin tedavide yeni uygulamas�. | |
BR9801839A (pt) | Medicamento analgésico e aplicação de (+) -0-demetiltramadol. | |
HUT75711A (en) | The use of dimeticone as a transport and carrier system and/or drug delivery system, and pharmaceutical compositions containing dimeticone | |
TH57760B (th) | การลำเลียงยาสู่ลำไส้เล็กและลำไส้ใหญ่โดยใช้แคปซูลชนิด hpmc | |
JO1880B1 (en) | Format 1 for multi-unit calibration discs |